Axel Dignass
@DignassAxel
Followers
498
Following
290
Media
13
Statuses
313
UEG Past President
Frankfurt am Main, Deutschland
Joined March 2019
In this episode, @egledie talks to former UEG President @DignassAxel about leading through crisis. Axel shares lessons from COVID-19 on empathy, resilience, and spotting toxic leadership. 💬 "A boss gives orders, a leader inspires and motivates." 🔗 https://t.co/Zlw5se73Jg
2
2
3
💡FDA vs. EMA on #UC trial guidance https://t.co/UqxH9D9yfg 👉FDA pushes full colonoscopy & maintenance of remission as new endpoints 👉EMA remains more flexible ⚠️ Lack of harmonization = more trials, slower approvals, patient burden. #IBD #UC #FDA #EMA #ClinicalTrials
1
6
34
GALAXI 2 and 3 trials of guselkumab maintenance in patients with Crohns disease just published 🌟Guselkumab superior to placebo and ustekinumab @TheLancet @LancetGastroHep @geteccu @sepdigestiva @aegastro ➡️ https://t.co/q6yG2KHjFe
4
36
89
🚨We are excited to host Dr. Axel Dignass as our Global IBD Visiting Professor @ClevelandClinic next week. 🗓️Join us on Tuesday, June 17th, 7AM EST for a live virtual event. Register FREE here👉: https://t.co/MXWVymbX2I
@MRegueiroMD @MichelleKimMD @IBD_FloMD @SaraElOualiMD
0
8
24
💎Join us tomorrow 06/17 for our Virtual Global Visiting Professorship live broadcast with Prof. @DignassAxel @ClevelandClinic Topic - "Teaching New Tricks to An Old Horse: 5-ASA and Immunomodulator Use in IBD". Register here👉: https://t.co/MXWVymbX2I
0
8
25
Kick off for the in person visit of our global #IBD visiting professor @DignassAxel (Axel Dignass) @ClevelandClinic, a true giant and leader in the field. Looking forward to two talks tomorrow. @MRegueiroMD @HolubarStefan @Psylupe @GI_PharmD @ManuelBragaMD @JosephHabibi_MD
1
8
43
Großartiger Auftakt zum 36. Kolloquium CED im Rahmen der DGIM 2025 mit Unterstützung der Falk Foundation. Full House. Tolle Vortäge, ausgezeichnete Referenten und Moderatoren. #falkfoundation,#axel Dignass,#irina Blumenstein
1
0
4
Luc Biedermann at #Falksymposium238 presenting on biological treatments in EoE. @IBD_USZ , Great job.
1
1
12
Tagesaktuelle Kurzvideos von der UEGW 2024 aus Wien | Takeda Gastroenterologie
1
0
3
@silvio_silvio75 leading us through the #IBD galaxy #Viszeralmedizin2024 Thank you for coming to 🇩🇪 and providing lot‘s of food for thoughts. @DignassAxel @I_Blumenstein @RajaAtreya @MWiestler @GastroFlo @KonradAden
2
3
8
🚨Assessment of #intestinal #inflammation via fecal #calprotectin💩 for early prediction of adverse outcomes in advanced #chronic #liver 🍑 #disease 📕only in @UEGJournal 🤗 https://t.co/9WGvtVjErk
@campani_claudia
@my_ueg
#UEGJFridays #LiverTwitter
#GITwitter #myUEGcommunity
0
19
40
FCP is better for colonic > small bowel (SB) inflammatiin, but how accurate is it in proximal vs. distal SB? Using VCE as gold standard, our @sheba_medical brilliant fellow @OffirU reports in @JCC_IBD a dilutional gradient of calpro along the SB ! https://t.co/1bizDkwNaG
5
46
105
Thank you very much @HelmsleyTrust for supporting the #STARConsortium and for highlighting our recent consensus publication. 🙏@IBD_FloMD
@Y_ECCO_IBD @alearmuzzi @FernandoMagro6 @pakotze @RPanaccione @TakuKobayashiM1 @DCharabaty @DignassAxel @maria_chs
The STAR Consortium recently published a Consensus Statement that provides critical clinical practice guidance on definitions, diagnosis, treatment, and long-term management of patients with fibrostenotic (fibrosis and stricturing) Crohn’s disease to improve the care of these
0
7
16
🌈Future of 🇩🇪 Hepatology @Wedemeyer_Lab 🔑attract talent #StefanZeuzem 🧱Make us visible #christophsarrazin 💪Integrated endoscopy ultrasound oncology in 🇩🇪 Hepatology @Tacke_lab @MHH_life
1
2
12
Congratulations! Fantastic update 🤩 Relevant changes from 2019 ✅do not stop biologicals prior surgery (2019 was conditional) ❌no fibrin glue for perianal ✅IFX & ADA for perianal ❓VEDO, UST, RIS, UPA in perianal And much more relevant data! Definitely 👍
Hot off the press : the #ECCO 2024 #Guidelines on Therapeutics in #CD: Medical Treatment. Excellently lead by Hannah Gordon and @IBD_MB, in close collaboration with ECCO GuiCom, @efcca and many clinicians globally. @Y_ECCO_IBD
https://t.co/WvCAWePVfQ
6
24
71
🚨This has been a huge effort by a group of dedicated #IBD-ologists and patient representatives. Indeed, great lead by @IBD_MB and #HannahGordon. Very happy to have contributed and hoping the result will positively impact the life of patients with #IBD
Hot off the press : the #ECCO 2024 #Guidelines on Therapeutics in #CD: Medical Treatment. Excellently lead by Hannah Gordon and @IBD_MB, in close collaboration with ECCO GuiCom, @efcca and many clinicians globally. @Y_ECCO_IBD
https://t.co/WvCAWePVfQ
0
10
32
Wonderful mentor. Outstanding person and contributions to GI
Very special evening celebrating Brian and immense contributions to people living with IBD. Presenting him with a binder of all his RCTs from cyclosporine 1994 to today brought memories of the story in every clinical trial. A true mentor to all those who have had the privilege
0
0
7
Wonderful piece of work. Congrats
This work took 3⃣ years from conception to publication in @NatureRevGastro ‘A global consensus on definitions, diagnosis and management of fibrostenosing small bowel Crohn’s disease in clinical practice’ Essentials on this challenging #IBD treatment situation in a 🧵 1/11
0
2
11
Thank you very much @pakotze It is a real pleasure and honor to discuss #IBD with friends in beautiful 🇧🇷
Fantastic guest on n Brazil today! @BettenworthDb contributing to IBD management in 🇧🇷 and Latin America.
1
1
18
#Choy: PREDICT UC: OPTIMISING INFLIXIMAB INDUCTION THERAPY FOR ACUTE SEVERE ULCERATIVE COLITIS - A RANDOMISED CONTROLLED TRIAL #DDW2024
@Y_ECCO_IBD @fgomollon @IBD_FloMD @AshkanRA @DCharabaty @I_Blumenstein @QueirozNataliaF @RestelliniS
0
11
33